{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:59:23Z","timestamp":1771549163580,"version":"3.50.1"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Attention Deficit\/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that has long been considered a concern only in the pediatric population. However, symptoms often sustain into adulthood and may require medication. For women with ADHD, this also means dealing with the disorder during the reproductive period. Medication safety during pregnancy and breastfeeding is a critical concern, and the potential transfer of ADHD medication to infants remains a topic of scientific interest. The quantification of ADHD medications in both maternal blood and breast milk are vital for understanding their pharmacokinetics and potential exposure risks for (nursing) infants. This review aims (1) to compile and critically assess existing research on the transfer of ADHD medications into breast milk and the potential implications for nursing infants and (2) to provide a comprehensive overview and discussion of the literature regarding the quantification of methylphenidate, amphetamine, atomoxetine, viloxazine, guanfacine, clonidine and bupropion in the blood, urine, oral fluid, and breast milk with liquid chromatography. A literature search was conducted using PubMed, Scopus, and Web of Science, to identify relevant articles published from January 2014 up to December 2023. We illustrate the lack of methods to simultaneously monitor multiple ADHD medications as well as the lack of developed methods for breast milk. Finally, we highlight the need for continued research to refine our understanding of medication transfer into breast milk and potential risks, and to develop clinical guidelines to support mothers with ADHD in making informed choices regarding medication use during pregnancy and lactation.<\/jats:p>","DOI":"10.3389\/fpubh.2024.1437328","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:37:25Z","timestamp":1723005445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review"],"prefix":"10.3389","volume":"12","author":[{"given":"Lena","family":"De Hondt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cosemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Plusquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby","family":"Mangelings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Van Eeckhaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Tommelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"ref1","volume-title":"Diagnostic and statistical Mannual of mental disorders","year":"2013"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1185\/03007995.2013.812961","article-title":"Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines","volume":"29","author":"Ramos-Quiroga","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eurpsy.2018.11.001","article-title":"Updated European consensus statement on diagnosis and treatment of adult ADHD","volume":"56","author":"Kooij","year":"2019","journal-title":"Eur Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S2215-0366(16)30190-0","article-title":"Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies","volume":"3","author":"Sibley","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"101780","DOI":"10.1016\/j.eclinm.2022.101780","article-title":"Attention-deficit\/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study","volume":"58","author":"Chan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s40263-021-00825-w","article-title":"Viloxazine in the management of CNS disorders: A historical overview and current status","volume":"35","author":"Findling","year":"2021","journal-title":"CNS Drugs"},{"key":"ref8","year":""},{"key":"ref9","year":""},{"key":"ref10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/pds.3600","article-title":"Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register-based study","volume":"23","author":"Haervig","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00228-022-03428-6","article-title":"Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010\u20132019","volume":"79","author":"Cohen","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.15585\/mmwr.mm6702a3","article-title":"Attention-deficit\/hyperactivity disorder medication prescription claims among privately insured women aged 15\u201344 years \u2014 United States, 2003\u20132015","volume":"67","author":"Anderson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/1087054718759753","article-title":"ADHD medication use during pregnancy and risk for selected birth defects: National Birth Defects Prevention Study, 1998-2011","volume":"24","author":"Anderson","year":"2020","journal-title":"J Atten Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1040824","DOI":"10.3389\/frph.2022.1040824","article-title":"Obstetric complications in mothers with ADHD","volume":"4","author":"Walsh","year":"2022","journal-title":"Front Reprod Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/jmwh.12671","article-title":"Attention-deficit hyperactivity disorder: clinical considerations for women","volume":"62","author":"Marraccini","year":"2017","journal-title":"J Midwifery Womens Health"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s11095-017-2323-z","article-title":"Pharmacological treatment of attention deficit hyperactivity disorder during pregnancy and lactation","volume":"35","author":"Ornoy","year":"2018","journal-title":"Pharm Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s40263-020-00728-2","article-title":"Pregnancy-related and offspring outcomes: A systematic review","volume":"34","author":"Li","year":"2021","journal-title":"CNS Drugs"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40263-018-0505-9","article-title":"Perinatal outcomes of women diagnosed with attention-deficit\/hyperactivity disorder: an Australian population-based cohort study","volume":"32","author":"Poulton","year":"2018","journal-title":"CNS Drugs"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2174\/1570159X18666201127164000","article-title":"The effects of drugs used for the treatment of attention deficit hyperactivity disorder (ADHD) on pregnancy outcome and breast-feeding: A critical review","volume":"19","author":"Ornoy","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2021.01.002","article-title":"Parental ADHD in pregnancy and the postpartum period \u2013 A systematic review","volume":"2021","author":"Kittel-Schneider","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ogc.2018.04.010","article-title":"Management of Attention Deficit Hyperactivity Disorder during Pregnancy","volume":"45","author":"Baker","year":"2018","journal-title":"Obstet Gynecol Clin N Am"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"12136","DOI":"10.4088\/JCP.18f12136","article-title":"Risk of major congenital malformations associated with the use of methylphenidate or amphetamines in pregnancy","volume":"79","author":"Andrade","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"ref24","first-page":"12","article-title":"Risico\u2019s bij gebruik van illegale middelen tijdens de zwangerschap","volume":"2","author":"Abdulhakim","year":"2022","journal-title":"Verslaving Herstel Zwangerschap"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/pds.4716","article-title":"Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta-analysis","volume":"28","author":"Jiang","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.reprotox.2020.03.003","article-title":"Fetal safety of methylphenidate\u2014A scoping review and meta analysis","volume":"93","author":"Koren","year":"2020","journal-title":"Reprod Toxicol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40264-014-0168-5","article-title":"ADHD treatment and pregnancy","volume":"37","author":"Besag","year":"2014","journal-title":"Drug Saf"},{"key":"ref28","year":""},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/pds.5654","article-title":"Trajectories of ADHD medication use before, during, and after pregnancy: A population-based study from Norway and Sweden","volume":"32","author":"Srinivas","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref30","volume-title":"Exclusive breastfeeding for six months best for babies everywhere","year":"2011"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/bfm.2017.0126","article-title":"Infant exposure to methylphenidate and duloxetine during lactation","volume":"13","author":"Collin-L\u00e9vesque","year":"2018","journal-title":"Breastfeed Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00007691-200504000-00056","article-title":"Infant dose and safety of breastfeeding for dexamphetamine and methylphenidate in mothers with attention deficit hyperactivity disorder 40","volume":"27","author":"Hackett","year":"2005","journal-title":"Ther Drug Monit"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1176\/ajp.2007.164.2.348","article-title":"Excretion of methylphenidate in breast milk","volume":"164","author":"Spigset","year":"2007","journal-title":"Am J Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2125.2006.02767.x","article-title":"Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder","volume":"63","author":"Ilett","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0378-3782(88)90015-1","article-title":"Clonidine: placental transfer and neonatal adaption","volume":"17","author":"Boutroy","year":"1988","journal-title":"Early Hum Dev"},{"key":"ref36","first-page":"598","article-title":"Pharmacokinetics of clonidine during pregnancy and nursing","volume":"69","author":"Hartikainen-Sorri","year":"1987","journal-title":"Obstet Gynecol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.arcped.2013.11.004","article-title":"Transplacental or breast milk intoxication to clonidine: a case of neonatal hypotonia and drowsiness","volume":"21","author":"Sevrez","year":"2014","journal-title":"Arch Pediatr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4088\/jcp.07l03133","article-title":"Bupropion levels in breast Milk fir 4 mother-infant pairs: more answers to lingering questions","volume":"70","author":"Linda","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/tc.2003.004093","article-title":"Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use","volume":"13","author":"Haas","year":"2004","journal-title":"Tob Control"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/106002809302700406","article-title":"Excretion of bupropion in breast Milk","volume":"27","author":"Briggs","year":"1993","journal-title":"Ann Pharmacother"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4088\/JCP.v65n0622f","article-title":"Bupropion and breastfeeding: A case of a possible infant seizure","volume":"65","author":"Chaudron","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/10826076.2017.1369994","article-title":"Extraction, preconcentration, and determination of methylphenidate in urine sample using solvent bar microextraction in combination with HPLC\u2013UV: optimization by experimental design","volume":"40","author":"Maddadi","year":"2017","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.13005\/bpj\/546","article-title":"Hollow-Fiber liquid-phase microextraction followed by high performance liquid chromatography for the determination of trace amounts of methylphenidate hydrochloride in biological fluids","volume":"7","author":"Miraee","year":"2014","journal-title":"Biomed Pharmacol J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.34172\/apb.2022.054","article-title":"Clinical application study of polymeric Nanospheres network in methylphenidate extraction from urine samples by dispersive solid phase extraction adsorbent","volume":"12","author":"Taghvimi","year":"2022","journal-title":"Adv Pharm Bull"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4155\/bio-2018-0024","article-title":"Novel and rapid LC-MS\/MS method for quantitative analysis of methylphenidate in dried blood spots","volume":"10","author":"Gandhi","year":"2018","journal-title":"Bioanalysis"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/j.forc.2022.100400","article-title":"Chiral separation and quantification of d,l-methylphenidate, d,l-ethylphenidate and ritalinic acid in blood by LC-MS\/MS","author":"Smith","year":"2022","journal-title":"Forensic Chem"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1021\/jm0490989","article-title":"Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol","volume":"48","author":"Patrick","year":"2005","journal-title":"J Med Chem"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jchromb.2018.06.025","article-title":"Rapid quantitative analysis of methylphenidate and ritalinic acid in oral fluid by liquid chromatography triple quadrupole mass spectrometry (LC-QqQ-MS)","volume":"1092","author":"Mulet","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jpba.2017.10.009","article-title":"Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of dexamphetamine in human plasma","volume":"30","author":"Herbrink","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jchromb.2017.08.027","article-title":"Molecularly imprinted polymer-sol-gel tablet toward micro-solid phase extraction: II. Determination of amphetamine in human urine samples by liquid chromatography\u2013tandem mass spectrometry","volume":"1063","author":"El-Beqqali","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bmc.3812","article-title":"Method validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC\u2013MS\/MS","volume":"31","author":"Comiran","year":"2017","journal-title":"Biomed Chromatogr"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"881198","DOI":"10.3389\/fphar.2022.881198","article-title":"Single dose comparative bioavailability study of Lisdexamfetamine dimesylate as Oral solution versus reference hard capsules in healthy volunteers","volume":"13","author":"Rizea-Savu","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/rcm.6844","article-title":"Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis","volume":"28","author":"Thevis","year":"2014","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00216-016-0056-1","article-title":"Accelerated quantification of amphetamine enantiomers in human urine using chiral liquid chromatography and on-line column-switching coupled with tandem mass spectrometry","volume":"409","author":"H\u00e4dener","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jat\/bkaa170","article-title":"Use of Lisdexamfetamine or amphetamine? Interpretation of chiral amphetamine analyses","volume":"46","author":"Cherm\u00e1","year":"2022","journal-title":"J Anal Toxicol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clinms.2019.04.002","article-title":"Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse\u00ae) using oral fluid as specimen","volume":"14","author":"B\u00f6ttcher","year":"2019","journal-title":"Clin Mass Spectr"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1007\/s00216-014-7850-4","article-title":"Enantioselective quantitative analysis of amphetamine in human plasma by liquid chromatography\/high-resolution mass spectrometry","volume":"406","author":"Leis","year":"2014","journal-title":"Anal Bioanal Chem"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00702-022-02483-8","article-title":"Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit\/ hyperactivity disorder: a naturalistic study","volume":"129","author":"Ruppert","year":"2022","journal-title":"J Neural Transm"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5414\/CP203705","article-title":"Determination of atomoxetine or escitalopram in human plasma by HPLC: applications in neuroscience research studies","volume":"58","author":"Teichert","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1039\/D1AY00521A","article-title":"Determination of atomoxetine levels in human plasma using LC-MS\/MS and clinical application to Chinese children with ADHD based on CPIC guidelines","volume":"13","author":"Xia","year":"2021","journal-title":"Anal Methods"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"114236","DOI":"10.1016\/j.jpba.2021.114236","article-title":"Simultaneous quantification of 19 analytes in breast milk by liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"204","author":"Monfort","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2174\/1573412918666220614144710","article-title":"Development and validation of A high-performance liquid chromatography-mass spectroscopy assay for the bioequivalence study of Guanfacine extended release (GXR) tablet in human plasma","volume":"18","author":"Jinying Wang","year":"2022","journal-title":"Curr Pharm Anal"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/bmc.3450","article-title":"Validation of a HPLC-ESI MS\/MS method for the determination of clonidine in human plasma and its application in a bioequivalence study in Chinese healthy volunteers","volume":"29","author":"Zhuang","year":"2015","journal-title":"Biomed Chromatogr"},{"key":"ref64","first-page":"91","article-title":"LC-MS method for studying the pharmacokinetics and bioequivalence of clonidine hydrochloride in healthy male volunteers","volume":"8","author":"Danafar","year":"","journal-title":"Avicenna J Med Biotechnol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/FTD.0000000000000245","article-title":"Quantification of methylphenidate, dexamphetamine, and Atomoxetine in human serum and Oral fluid by HPLC with fluorescence detection","volume":"38","author":"Stegmann","year":"2016","journal-title":"Ther Drug Monit"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/1556-4029.14977","article-title":"Analysis of methylphenidate, ethylphenidate, lisdexamfetamine, and amphetamine in oral fluid by liquid chromatography-tandem mass spectrometry","volume":"67","author":"Smith","year":"2022","journal-title":"J Forensic Sci"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5478\/MSL.2014.5.4.104","article-title":"Simultaneous determination of methylphenidate, amphetamine and their metabolites in urine using direct injection liquid chromatography-tandem mass spectrometry","volume":"5","author":"Kwon","year":"2014","journal-title":"Mass Spectr Lett"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1371\/journal.pone.0260279","article-title":"Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method","volume":"16","author":"Coache","year":"2021","journal-title":"PLoS One"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jpba.2017.05.018","article-title":"UHPLC\u2013MS\/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples","volume":"142","author":"De Nicol\u00f2","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jpba.2016.07.049","article-title":"UHPLC\u2013MS\/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients","volume":"129","author":"De Nicol\u00f2","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"755184","DOI":"10.3389\/fphar.2021.755184","article-title":"A non-invasive method for detection of antihypertensive drugs in biological fluids: the salivary therapeutic drug monitoring","volume":"12","author":"Avataneo","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.15587\/2519-4852.2020.215101","article-title":"Identification and quantitative determination of clonidine by HPLC method. ScienceRise: pharmaceutical","volume":"27","author":"Mamina","year":"2020","journal-title":"Science"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/bmc.3393","article-title":"Development of an LC-MS\/MS method for determining the pharmacokinetics of clonidine following oral administration of Zhenju antihypertensive compound","volume":"29","author":"Qin","year":"2015","journal-title":"Biomed Chromatogr"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1002\/bmc.4527","article-title":"Validation of a HPLC\/MS method for simultaneous quantification of clonidine, morphine and its metabolites in human plasma","volume":"33","author":"Tang","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jchromb.2017.03.007","article-title":"A highly sensitive method for the simultaneous UHPLC\u2013MS\/MS analysis of clonidine, morphine, midazolam and their metabolites in blood plasma using HFIP as the eluent additive","volume":"1052","author":"Veigure","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/molecules25184109","article-title":"Development and validation of an HPLC-UV detection assay for the determination of clonidine in mouse plasma and its application to a pharmacokinetic study","volume":"25","author":"AlRabiah","year":"2020","journal-title":"Molecules"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10337-023-04293-w","article-title":"Pharmacokinetic, protein binding, and tissue distribution investigations of Viloxazine enantiomers in rat plasma by HPLC\u2013MS\/MS using polysaccharide-based immobilized chiral column: A preclinical approach to possible chiral switch","volume":"86","author":"Rayala","year":"2023","journal-title":"Chromatographia"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12888-017-1463-3","article-title":"Adult ADHD and comorbid disorders: Clinical implications of a dimensional approach","volume":"17","author":"Katzman","year":"2017","journal-title":"BMC Psychiatry"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.talanta.2018.02.039","article-title":"SUPRAS extraction approach for matrix-independent determination of amphetamine-type stimulants by LC-MS\/MS","volume":"182","author":"Accioni","year":"2018","journal-title":"Talanta"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.foodchem.2017.10.005","article-title":"Simultaneous LC\u2013MS\/MS determination of 40 legal and illegal psychoactive drugs in breast and bovine milk","volume":"245","author":"L\u00f3pez-Garc\u00eda","year":"2017","journal-title":"Food Chem"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1373\/clinchem.2009.138396","article-title":"Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma","volume":"56","author":"Marchei","year":"2010","journal-title":"Clin Chem"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/bdd.2254","article-title":"Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine","volume":"42","author":"Comiran","year":"2021","journal-title":"Biopharm Drug Dispos"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1437328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:37:29Z","timestamp":1723005449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1437328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":82,"alternative-id":["10.3389\/fpubh.2024.1437328"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1437328","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"article-number":"1437328"}}